Company Updates
RayGen Receives $1m Grant from Victorian State Government
The Victorian state government in Australia is providing AUD 1 million in funding for a 0.5-MW commercial concentrated solar photovoltaic (CSPV) plant of Australian solar technology company.
Lodge Partners Latest Research & Valuation Report on Leaf Resources (ASX: LER)
Lodge Partners have released its latest research and valuation report on Leaf Resources Limited (ASX:LER). The report maintained a BUY rating and a price target of $0.35 per share.
Nvoi (ASX: NVO) Signs First Corporate Client, Integrated Research
Nvoi is pleased to announce Integrated Research as a new Corporate Client on the Nvoi digital platform. This comes just three months after Nvoi launched its enhanced end to end platform.
Surflakes ESIC
Surf Lakes Holdings Ltd is an innovative, early stage company that is looking for quick and effective commercialisation of their market leading offering to capitalise on their competitive advantages.
ESIC-Approved Secure2Go Signs MOU with Leading Global Insurer MunichRE
Secure2Go designs and delivers enterprise-grade product solutions to end users enabling real time monitoring and managing of “out of sight” assets.
DMX ASSET MANAGEMENT Releases Their “Strategies to Sleep Well for Small Cap Investors”
DMX Asset Management Ltd is a Sydney-based boutique asset manager focused on long term value investing.
Antisense Therapeutics ATL1102 for MS Phase IIB IND Submitted to FDA for Approval
Antisense Therapeutics (ANP) has advised that the ATL1102 for Multiple Sclerosis (MS) Phase IIb IND application has been submitted to the US Food and Drug Administration (FDA) for its review.
Antisense Therapeutics To Undertake Clinical Trial of ALT1102 in Duchenne Muscular Dystrophy at the Melbourne Royal Children’s Hospital
Antisense Therapeutics has announced that the company has undertaken advanced planning for the clinical trial of ALT1102.
Cre8tek (ASX: CR8) Crosses a Major Milestone in its Agreement with US-Based Fortune 100 Insurance Firm Nationwide
Cre8tek Limited (ASX: CR8), owner of high-tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc.
Backed By Leading Investment Groups and Family Offices
